Results 231 to 240 of about 6,650,662 (298)
Pareto-Guided Process Optimization of Single-Crystal InP Chemical Mechanical Polishing: Balancing Material Removal Rate and Surface Roughness. [PDF]
Deng J +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pharmacogenomics, 2003
Etiologics is an innovative drug discovery company that, unlike most new companies in this sector, has a balanced portfolio of ethylnitrosourea (ENU) technology, animal models of disease, in vitro cell function models, and expertise in drug discovery, which spans the whole drug discovery process.
David A, Campbell, Mary F, Fitzgerald
openaire +2 more sources
Etiologics is an innovative drug discovery company that, unlike most new companies in this sector, has a balanced portfolio of ethylnitrosourea (ENU) technology, animal models of disease, in vitro cell function models, and expertise in drug discovery, which spans the whole drug discovery process.
David A, Campbell, Mary F, Fitzgerald
openaire +2 more sources
Personalized Medicine, 2005
DxS is a personalized medicine company focused on providing genetic analysis services and technologies to enable the delivery of safe and effective medicines. The services provide support for drug development, diagnostic product development and pharmacodiagnostics.
openaire +2 more sources
DxS is a personalized medicine company focused on providing genetic analysis services and technologies to enable the delivery of safe and effective medicines. The services provide support for drug development, diagnostic product development and pharmacodiagnostics.
openaire +2 more sources
Pharmacogenomics, 2004
Solexa Ltd is developing an integrated system, based on a breakthrough single molecule sequencing technology, to address a US$2 billion market that is expected to grow exponentially alongside and as a consequence of further technological enhancements. The system, software and consumables will initially be sold to research organizations, pharmaceutical ...
openaire +2 more sources
Solexa Ltd is developing an integrated system, based on a breakthrough single molecule sequencing technology, to address a US$2 billion market that is expected to grow exponentially alongside and as a consequence of further technological enhancements. The system, software and consumables will initially be sold to research organizations, pharmaceutical ...
openaire +2 more sources

